Categories Analysis, Industrials

FedEx (FDX) probably had another weak quarter. Here’s why

FedEx is scheduled to publish Q3 2023 results on Wednesday, amid expectations for a decline in earnings

The slowdown in the US economy and high inflation is taking a toll on the cargo industry, at a time when parcel service giants like FedEx Corporation (NYSE: FDX) are facing a demand slump after the pandemic-driven delivery boom cooled off. While external conditions continue to be challenging, FedEx has initiated an organizational restructuring, with a focus on aggressive cost reduction.

In general, experts are optimistic about the prospects of the company’s stock this year, though the consensus estimates indicate only modest gains. The stock has been a favorite among income investors, thanks to the regular dividend hikes and decent yield.  However, FDX’s performance ahead of the earnings has not been very encouraging.

Valuation

Despite its gradual withdrawal from the 2021 peak, the stock looks almost fully valued. Together with the weak earnings estimates, the current valuation calls for caution. The market will be closely following this week’s earnings, looking for cues on where the company is headed. So, it would be a good idea to hold buying/selling decisions until that.


FedEx Corporation Q2 2023 Earnings Call Transcript


The economic and geopolitical backdrop is not favorable for FedEx – the Russia-Ukraine war continues to disrupt freight movement in that region while muted demand weighs on volumes in Asia, prompting the management to reduce capacity. Meanwhile, the recent improvement in yield is a bright spot as the trend is expected to continue. Earlier, the company had raised package delivery rates to revive margins.

FedEx-Q2-2023-Earnings-Infographic

Cost Reduction

Falling sales and softening profits made the company extend the cost-cutting drive it had initiated last year. The measures include capacity reduction and closure of certain offices, mainly focused on the Express division that is badly affected by the market headwinds. When the company releases third-quarter results on Thursday, after the official trading hours, the market will be looking for a sharp fall in adjusted earnings to $2.71 per share. The projection reflects an estimated 3.6% drop in revenues to $22.79 billion.

From FedEx’s Q2 2023 earnings call:

“As we look toward the back half, service improvement has translated into good momentum for our sales team. In addition, we have a robust pipeline aligned with our strategy, which includes small and medium, and European segment targets. In Q4, we will be lapping the impact of the beginning of the war in Ukraine as well as the air integration disruption we experienced in the region. As a result, our year-over-year volume comps will improve as we move through the back half of this fiscal year.”

Financials

The company ended the first half of fiscal 2023 on a positive note, reporting bigger-than-expected earnings for the second quarter, which marked the second beat in a row after two consecutive misses. Net profit, adjusted for special items, plunged 34% year-over-year to $3.18 per share. At $22.8 billion, second-quarter revenues were down 3%. A contraction in the core Express segment was more than offset by growth in the Ground and Freight divisions.


UPS Q4 2022 Earnings: Key financials and quarterly highlights


FedEx’s shares declined on Monday and traded below $200 during the session, extending the recent weakness. It lost about 6% in the past thirty days alone.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted

Unicycive is all-in on kidney care, focusing on underserved areas: CEO

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with renal diseases. In an email interview with AlphaStreet, CEO Dr.

Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top